Trial site
Michigan State University Clinical Center
East Lansing, Michigan 48824, United StatesNot linked to an institution yet
- 3running trials
- 15closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Phase
- Phase 37 trials
- Phase 26 trials
- Phase 2/31 trial
- Status
- Completed15 trials
- Active, not recruiting3 trials
- Lead sponsor
- National Cancer Institute (NCI)10 trials
- Children's Oncology Group4 trials
- Alliance for Clinical Trials in Oncology1 trial
- ECOG-ACRIN Cancer Research Group1 trial
- National Heart, Lung, and Blood Institute (NHLBI)1 trial
- and 1 more
Closed trials
Completed
Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer
NCT03382561· Phase 2· National Cancer Institute (NCI)· Source
Completed
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
NCT03213678· Phase 2· National Cancer Institute (NCI)· Source
Completed
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
NCT02828358· Phase 2· National Cancer Institute (NCI)· Source
Completed
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
NCT02844816· Phase 2· National Cancer Institute (NCI)· Source
Completed
The National Myelodysplastic Syndromes (MDS) Study
NCT02775383· National Heart, Lung, and Blood Institute (NHLBI)· Source
Completed
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
NCT01979536· Phase 2· National Cancer Institute (NCI)· Source
Completed
Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
NCT01553149· Phase 2· National Cancer Institute (NCI)· Source
Completed
Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
NCT01236560· Phase 2/3· National Cancer Institute (NCI)· Source
Completed
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
NCT00601900· Phase 3· National Cancer Institute (NCI)· Source
Completed
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00557193· Phase 3· Children's Oncology Group· Source
Completed
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
NCT00324805· Phase 3· National Cancer Institute (NCI)· Source
Completed
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
NCT00408005· Phase 3· National Cancer Institute (NCI)· Source
Completed
Study of Kidney Tumors in Younger Patients
NCT00898365· Children's Oncology Group· Source
Completed
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
NCT00082745· Children's Oncology Group· Source
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
NCT00904241· Children's Oncology Group· Source
Report an error